Recombinant human insulin (United Laboratories International Holdings)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human insulin (United Laboratories International Holdings)
Drug Alias Name重组人胰岛素（联邦制药）优思灵Uslin优思灵R
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryMainland China
Original Approved Date2009/11/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesZhongshan Branch of Zhuhai United Laboratories Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhongshan Branch of Zhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksWikipediaDrugBankKEGG